Boston, MA, United States of America

Klaus Dembowsky

USPTO Granted Patents = 46 


Average Co-Inventor Count = 9.8

ph-index = 18

Forward Citations = 1,142(Granted Patents)


Location History:

  • Wuppertal, DE (1996 - 1998)
  • Schriesheim, DE (2000 - 2004)
  • Munich, DE (2005 - 2006)
  • München, DE (2008)
  • Boston, MA (US) (2002 - 2012)

Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Adenosine Receptor Selective Ligands
Phosphodiesterase Inhibitors
Aminodicarboxylic Acid Derivatives
Pyrazolopyridine Derivatives
Imidazotriazinones
Dicarboxylic Acid Derivatives
Cardiovascular Preparations
Sulfonamide-Substituted Compounds
Heterocyclic Compounds
Triazolotriazinones
Medical Uses of Derivatives
Pharmaceutical Properties
46 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Klaus Dembowsky in Pharmaceutical Patents

Introduction

Klaus Dembowsky, based in Boston, MA, is a prominent inventor known for his significant contributions to the pharmaceutical industry, evidenced by his impressive portfolio of 46 patents. His work primarily focuses on innovative compounds for the treatment of various medical conditions, making him an esteemed figure in the field of medicinal chemistry.

Latest Patents

Among his latest inventions, Dembowsky has developed "Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands". This patent details a novel compound aimed at creating effective pharmaceutical compositions for treating cardiovascular disorders and diabetes. Another significant patent is "Substituted 2-oxy-3,5-dicyano-4aryl-6-aminopyridines and use thereof". This invention outlines specific compounds and their pharmaceutical applications, emphasizing methods for treating various medical conditions.

Career Highlights

Dembowsky has a rich professional background, having worked with renowned companies such as Bayer Aktiengesellschaft and Bayer Schering Pharma AG. His tenure at these organizations has enabled him to apply his innovative ideas in practical settings, leading to advancements in pharmaceutical sciences and therapies.

Collaborations

Throughout his career, Klaus Dembowsky has collaborated with esteemed colleagues, including Elisabeth Perzborn and Johannes-Peter Stasch. These partnerships have been instrumental in the development of groundbreaking drugs and therapeutic solutions, allowing for shared expertise and knowledge in the pursuit of medicinal innovations.

Conclusion

Klaus Dembowsky's contributions to the pharmaceutical landscape through his inventive patents showcase his dedication to improving human health. With a focus on treating critical conditions such as diabetes and cardiovascular disorders, his work continues to inspire advancements in medicinal chemistry and pharmaceutical research. As he progresses in his career, the impact of his inventions remains significant in addressing healthcare challenges worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…